ASAnastasia O. Shmeleva

Anastasia O. Shmeleva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anastasia O. Shmeleva has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analysis of the state of intestinal microbiota by PCR in inflammatory bowel diseases in children

    by A. O. Shmeleva, E. N. Fedulova, I. V. Sadovnikova, A. A. Volkova, A. I. Khavkin

    Purpose - optimize the treatment of patients with ulcerative colitis (UC) and Crohn’s disease (CD), taking into account the bacterial diversity of the intestinal microbial flora in inflammatory bowel diseases. Materials and methods: The study analyzed the results of colonoflora of 243 patients hospitalized in 2021-2023 in the 1st pediatric department of the University Clinic of the Federal State Budgetary Educational Institution “PIMU” of the Ministry of Health of the Russian Federation with confirmed UC (61.7%, n=150/243) and CD (38.3%, n=93/243). The diagnosis was established on the basis of generally accepted criteria in accordance with ECCO recommendations. Of these, 134 are boys (55.1%) and 109 are girls (44.9%). All children were divided into the following age groups, according to the WHO classification: 1-3 years old, 6 patients (2.5%), 3-7 years old - 25 patients (10.3%), boys 7-12 years old - 44 patients (18.1%), girls 7-11 years old - 25 patients (10.3%), boys 12-16 years old - 53 patients (21.8%), girls 11-15 years old - 40 (16.5%), boys 16-21 years old - 20 (8.2%), girls 15-20 years old - 30 (12.3%). The PCR method was used in the work, which allows using the Colonoflor-16 test system (manufacturer Alfalab company (St. Petersburg)) to quantify the state of the microbiocenosis of the large intestine in children and adults in real time. Results: In the course of the work, it was proved that inflammatory bowel diseases are directly related to changes in the composition of the microbiota, since in UC and CD, changes other than the normoflora of the colon were observed in 99% of cases. There were significant differences in the microbial landscape with different flow variants. In addition, Crohn’s disease and ulcerative colitis have a number of differences between representatives of the microbiota of the colon. In ulcerative colitis, a decrease in lactobacilli is more often observed, p= 0.033. In Crohn’s disease, an increase in Staphylococcus aureus bacteria (p=0.001) and an increase in Clostridium perfringens (p=0.026) were more often detected. Conclusion: Thus, when diagnosing ulcerative colitis and Crohn’s disease, it is necessary to examine the microbiota and subsidize differentiated probiotic groups of bacteria during the follow-up period, since in 58%-70% of cases there was a decrease in lactobacilli. p=0.033.

  • Clinical relevance of plasma cystatin C in the diagnosis of acute kidney injury in preterm infants

    by Anastasia A. Volkova, Elena M. Kozlova, Ekaterina G. Novopoltseva, Galina L. Shunkina, Anastasia N. Kolchina, Nadezhda A. Rakhmanova, Anastasia O. Shmeleva

    BACKGROUND: Acute kidney injury is one of the most common syndromes in premature neonates requiring treatment in intensive care units. Early diagnosis of acute kidney injury in these patients is extremely difficult due to lack of specific signs, morphofunctional immaturity, low sensitivity and specificity of renal dysfunction markers. AIM: The aim of the study is to assess the clinical significance of plasma cystatin C concentration in the diagnosis of acute kidney injury in premature newborns in the early neonatal period. MATERIALS AND METHODS: The design was a primary, prospective, non-randomised study including 100 preterm neonates with gestational age less than 37 weeks and birth weight up to 1500 g. Indicators of renal functional status (creatinine, diuresis rate, cystatin C) were assessed on the first, third and seventh days of life. RESULTS: Low birth weight (p = 0.001; OR = 0.226), the need for invasive control mechanical ventilation (p = 0.012; OR = 6.32) and inotropic therapy (p = 0.025; OR = 4.99) are associated with a high risk of acute kidney injury development. A direct correlation was found between the presence of acute kidney injury, plasma creatinine (p = 0.001, r = 0.688) and cystatin C (p = 0.001, r = 0.689) levels. The first increase in plasma creatinine levels relative to basal levels in preterm neonates with acute kidney injury was noted from the third day of life, which was statistically significant compared to those of children without acute kidney injury (91.0 vs 57.0 mmol/l; p 0.001). The concentration of cystatin C in patients with acute kidney injury is increased from the first day of life (1.85 vs 1.57 ng/ml) and continues to steadily increase by the seventh day of life (2.27 vs 1.84 ng/ml; p 0.001). CONCLUSIONS: Increased concentration of cystatin C in preterm neonates with acute kidney injury is observed from the first day of life and increases in dynamics, which allows us to consider it a highly sensitive and significant marker of renal dysfunction in the early neonatal period.